StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CANN

Trees Corporation

CANN OTC Retail-Drug Stores and Proprietary Stores EDGAR ↗
$0.02
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$2.27M
Revenue (TTM) ⓘ
$14.5M
Net income (TTM) ⓘ
-$5.38M
EPS (TTM) ⓘ
$-0.03
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
-$1.19M
Cash ⓘ
$245K
Total assets ⓘ
$21.2M
Gross margin ⓘ
-0.5%
52-week range ⓘ
$0.00 – $0.06

AI briefing

from the latest 10-K, 10-Q and 8-K events

TREES Corporation is a small-scale cannabis retailer and cultivator operating five dispensaries in Colorado and Oregon along with two Colorado cultivation facilities.

What they do

TREES Corporation (formerly General Cannabis Corp) operates cannabis retail and cultivation assets in Colorado and Oregon. The company runs five dispensaries: three in Colorado (Englewood, Denver, Longmont) and two in Oregon (both in Portland). It also operates two cultivation facilities in Colorado under the SevenFive Farm and Hillside Cultivation names. Its business model is to acquire, integrate, and optimize cannabis companies in the retail and cultivation segments.

Revenue drivers

  • Retail dispensaries — Five cannabis dispensaries in Colorado and Oregon generate the bulk of revenue through direct sales to consumers, with licenses covering recreational and medical use depending on the location.
  • Cultivation (Hillside Cultivation) — Hillside Cultivation, a Colorado retail cultivation facility, sells to related-party dispensaries; during the nine months ended September 30, 2024, 98% of its revenue came from three related-party customers and is eliminated in consolidation.
  • Cultivation (SevenFive Farm) — SevenFive Farm, a Colorado retail cultivation facility, had zero revenue in the three months ended September 30, 2024; in the nine months ended September 30, 2024, 100% of its revenue came from three related-party customers and is eliminated in consolidation.

Recent performance

For the three months ended September 30, 2024, revenue fell 19% to $3.31 million from $4.11 million a year earlier. Costs and expenses decreased 24% to $3.58 million, but other expense jumped 176% to $573,709, driven by higher non-operating costs. The net loss before income taxes widened slightly to $845,348 from $815,123. For the nine months ended September 30, 2024, revenue dropped 25% to $10.69 million while costs fell 36% to $11.22 million. The company remains unprofitable, with a net loss before taxes of $1.51 million for the nine-month period, up 7% from the prior year.

Strategy

TREES aims to acquire, integrate, and optimize cannabis companies in the retail and cultivation segments. The company leverages a vertically integrated network of dispensaries and cultivation facilities to capture margin across the supply chain. Recent 8-K filings show a pattern of entering material agreements and taking on financial obligations, including as recently as August 2025. Management has not publicly detailed specific growth targets or capital expenditure plans in the excerpts provided. The company continues to operate in a challenging cannabis market with declining revenues.

Risks

  • Revenue concentration — Hillside Cultivation derived 98% of its nine-month 2024 revenue from three related-party customers, and SevenFive's revenue came entirely from three related parties, exposing the company to significant counterparty risk.
  • Negative shareholder equity — As of September 30, 2024, total liabilities of $23.8 million exceeded total assets of $21.2 million, resulting in negative shareholder equity of $2.6 million.
  • Limited cash position — The company held only $245,367 in cash and equivalents as of September 30, 2024, against $14.2 million in long-term debt, raising going-concern concerns.
  • Declining revenue — Revenue fell 19% year-over-year in Q3 2024 and 25% for the first nine months of 2024, indicating persistent top-line pressure.

Outlook

Management does not provide specific forward guidance in the excerpts. The company continues to face declining revenues and a weak balance sheet with negative equity and minimal cash. Recent 8-K filings indicate ongoing material agreements and financial obligations, but no concrete turnaround plan is detailed. Outlook remains uncertain given the challenging cannabis market and the company's financial position.

Recent SEC filings

40 most recent
Annual, quarterly & current reports